HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Farnesyltransferase inhibitors induce cytochrome c release and caspase 3 activation preferentially in transformed cells.

Abstract
Farnesyltransferase inhibitors (FTIs) represent a new class of anticancer drugs that show promise in blocking the growth of tumors. Here, we report that FTIs are capable of inducing apoptosis of transformed but not untransformed cells. Treatment of v-K-ras-transformed normal rat kidney (KNRK) cells with FTIs leads to the induction of apoptotic cell morphology, chromatin condensation and DNA fragmentation. In addition, fluorescence-activated cell sorter analysis of FTI-treated KNRK cells shows a sub-G1 apoptotic peak (chromosome content of <2 N). This FTI-induced apoptosis is evident only when the cells are grown in low serum conditions (0.1% fetal calf serum) and is observed selectively with transformed KNRK cells and not with untransformed NRK cells. Further analysis of the mechanism underlying this apoptosis has shown that FTI treatment of KNRK cells results in the activation of caspase 3 but not caspase 1. Moreover, the addition of Z-DEVD-fmk, an agent that interferes with caspase 3 activity, can inhibit FTI-induced apoptosis in a dose-dependent manner. Introduction of the CASP-3 gene into MCF7 cells, which lack caspase 3 activity, results in a significant increase of FTI-induced apoptosis. Furthermore, FTI induces the release of cytochrome c into the cytosol. This release is an important feature of caspase 3-mediated apoptosis. These results suggest that FTIs induce apoptosis through the release of cytochrome c from the mitochondria resulting in caspase 3 activation.
AuthorsN Suzuki, J Urano, F Tamanoi
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 95 Issue 26 Pg. 15356-61 (Dec 22 1998) ISSN: 0027-8424 [Print] United States
PMID9860973 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Androstadienes
  • Cytochrome c Group
  • Enzyme Inhibitors
  • Flavonoids
  • Indoles
  • Oligopeptides
  • benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone
  • DAPI
  • Alkyl and Aryl Transferases
  • Farnesyltranstransferase
  • CASP3 protein, human
  • Casp3 protein, rat
  • Caspase 3
  • Caspases
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
  • Wortmannin
Topics
  • Alkyl and Aryl Transferases (antagonists & inhibitors)
  • Androstadienes (pharmacology)
  • Animals
  • Apoptosis (drug effects)
  • Breast Neoplasms
  • Caspase 3
  • Caspases (metabolism)
  • Cell Line, Transformed
  • Cytochrome c Group (metabolism)
  • Cytosol (metabolism)
  • DNA Fragmentation (drug effects)
  • Enzyme Activation
  • Enzyme Inhibitors (pharmacology)
  • Farnesyltranstransferase
  • Female
  • Flavonoids (pharmacology)
  • Genes, ras
  • Humans
  • Indoles
  • Kidney
  • Mitochondria (drug effects, metabolism)
  • Oligopeptides (pharmacology)
  • Rats
  • Tumor Cells, Cultured
  • Wortmannin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: